This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Center for Outcomes Research | |
|---|---|
| Name | Center for Outcomes Research |
| Formation | 1990s |
| Type | Research institute |
| Location | United States |
| Leader title | Director |
| Leader name | John Doe |
Center for Outcomes Research is a multidisciplinary research institute that evaluates health, clinical, and programmatic outcomes across medical, public health, and social service settings. It synthesizes evidence from clinical trials, observational cohorts, administrative data, and implementation studies to inform decision-making by clinicians, payers, and policy makers. The center engages with academic partners, hospitals, regulatory agencies, and professional societies to translate findings into practice guidelines and quality metrics.
Founded in the late 20th century amid rising interest in comparative effectiveness, health services, and evidence synthesis, the Center for Outcomes Research was established by a consortium of university departments and healthcare systems. Early initiatives drew on methodologies developed at institutions such as Johns Hopkins University, Harvard University, Stanford University, University of California, San Francisco, and Mayo Clinic. Key formative collaborations included links with Centers for Disease Control and Prevention, National Institutes of Health, Agency for Healthcare Research and Quality, Institute of Medicine and regional health networks. The center expanded through the 2000s, aligning with national efforts exemplified by the Patient-Centered Outcomes Research Institute and international programs at World Health Organization affiliates. Leadership transitions involved scholars affiliated with Columbia University, Yale University, University of Michigan, and University of Pennsylvania.
The center's mission emphasizes rigorous evaluation of interventions to improve patient-centered outcomes, comparative effectiveness, and value-based care. Objectives include advancing methods pioneered by researchers at RAND Corporation, Cochrane Collaboration, and National Bureau of Economic Research; producing evidence to inform regulators such as Food and Drug Administration and payers like Centers for Medicare & Medicaid Services; and supporting guideline development for professional bodies including the American Medical Association and American College of Physicians. It aims to train investigators in analytic approaches used at International Society for Pharmacoeconomics and Outcomes Research and to disseminate findings through journals such as The New England Journal of Medicine, JAMA, and The BMJ.
Research spans comparative effectiveness, health-related quality of life, cost-effectiveness analysis, patient-reported outcomes, and implementation science. Methodological approaches incorporate randomized pragmatic trials reflecting designs used at ClinicalTrials.gov networks, observational designs leveraging administrative claims from Medicare and datasets curated by IBM Watson Health, and causal inference techniques drawn from work at University of California, Berkeley and London School of Hygiene & Tropical Medicine. Advanced analytics include machine learning frameworks related to projects at Massachusetts Institute of Technology, predictive modeling inspired by Carnegie Mellon University research, and Bayesian methods popularized through collaborations with University of Cambridge and University of Oxford. Measurement tools include instruments endorsed by National Quality Forum and outcome taxonomies aligned with World Health Organization standards.
The center has published landmark comparative studies assessing pharmacologic and procedural interventions first introduced in trials at Brigham and Women's Hospital, Cleveland Clinic, and Johns Hopkins Hospital. Studies addressed outcomes in chronic diseases managed at centers like Mount Sinai Health System and Massachusetts General Hospital, influencing guideline updates by American Heart Association and American Diabetes Association. Findings on cost-effectiveness influenced reimbursement decisions by Centers for Medicare & Medicaid Services and formulary committees at Blue Cross Blue Shield affiliates. Work on surgical outcomes paralleled registries run by American College of Surgeons and informed safety advisories from Joint Commission. Publications have appeared in outlets associated with New England Journal of Medicine, JAMA, The Lancet, and specialty journals from American Academy of Pediatrics and European Society of Cardiology.
Collaborative networks include academic hospitals such as UCLA Health, University of Washington Medical Center, and University of Texas Southwestern Medical Center, along with public agencies like National Institutes of Health institutes and state health departments. Partnerships extend to professional societies including Society for Clinical Trials, International Society for Pharmacoeconomics and Outcomes Research, and Society of Critical Care Medicine, and to patient advocacy groups such as American Cancer Society and Alzheimer's Association. Industry collaborations have involved pharmaceutical sponsors with oversight from Food and Drug Administration-aligned safety committees and data-sharing agreements with consortia like Observational Health Data Sciences and Informatics.
Funding sources encompass federal grants from National Institutes of Health, contracts with Agency for Healthcare Research and Quality, foundation support from entities such as Robert Wood Johnson Foundation and Bill & Melinda Gates Foundation, and investigator-initiated awards from professional societies. Governance typically includes an external advisory board with representatives from AcademyHealth, hospital systems, payers including Aetna, and members with affiliations to universities like University of Chicago and Duke University. Conflict-of-interest policies align with standards set by National Academies of Sciences, Engineering, and Medicine.
Research outputs have informed clinical practice guidelines produced by American College of Cardiology, influenced coverage determinations at Centers for Medicare & Medicaid Services, and shaped quality metrics adopted by National Quality Forum. Implementation studies have been integrated into hospital improvement programs at institutions such as Kaiser Permanente and Geisinger Health System. The center’s work has been cited in advisory reports to Food and Drug Administration panels and in policy analyses by think tanks including Brookings Institution and Urban Institute.
Facilities include biostatistics cores, health economics units, data warehouses linked to clinical partners like Partners HealthCare and computational labs modeled on infrastructure at Argonne National Laboratory for high-performance computing needs. Training programs offer fellowships and visiting scholar positions in collaboration with departments at Harvard T.H. Chan School of Public Health, Johns Hopkins Bloomberg School of Public Health, and London School of Hygiene & Tropical Medicine, plus short courses for clinicians co-sponsored by American Board of Internal Medicine and executive education with Wharton School.
Category:Health research institutes